Shardul Amarchand Mangaldas advises ChrysCapital
Law Firms NewsNews

The transaction comprises of a secondary acquisition of shares from the Promoters and Tata Capital Healthcare Fund II and, a primary subscription to shares proposed to be issued by the Target Company.